Signature Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.5M | Buy |
75,650
+488
| +0.6% | +$22.6K | 1.38% | 30 |
|
2025
Q1 | $4.58M | Buy |
75,162
+1,179
| +2% | +$71.9K | 1.79% | 15 |
|
2024
Q4 | $4.18M | Buy |
73,983
+1,547
| +2% | +$87.5K | 1.68% | 19 |
|
2024
Q3 | $3.75M | Buy |
72,436
+1,733
| +2% | +$89.7K | 1.5% | 28 |
|
2024
Q2 | $2.94M | Buy |
+70,703
| New | +$2.94M | 1.29% | 33 |
|
2018
Q4 | – | Sell |
-600
| Closed | -$30K | – | 98 |
|
2018
Q3 | $30K | Sell |
600
-11
| -2% | -$550 | 0.02% | 128 |
|
2018
Q2 | $34K | Hold |
611
| – | – | 0.03% | 120 |
|
2018
Q1 | $39K | Buy |
611
+11
| +2% | +$702 | 0.03% | 111 |
|
2017
Q4 | $37K | Buy |
+600
| New | +$37K | 0.03% | 115 |
|